US Patent 11466062 Ankyrin repeat binding proteins and their uses
All edits
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114660620
Date of Patent
October 11, 2022
0Patent Application Number
173135430
Date Filed
May 6, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 4 Apr, 2023
Golden AI
Infobox
Edits on 12 Oct, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+443 characters)
US Patent 11466062 Ankyrin repeat binding proteins and their uses
Article
The present invention relates to recombinant binding proteins comprising one or more designed ankyrin repeat domains with binding specificity for coronavirus spike proteins, nucleic acids encoding such proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of such proteins, nucleic acids or pharmaceutical compositions in the treatment of coronavirus diseases, particularly diseases caused by SARS-CoV-2.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114660620
Date of Patent
October 11, 2022
0Patent Application Number
173135430
Date Filed
May 6, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11466062 Ankyrin repeat binding proteins and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
